.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Oliver Schilling

Freiburg / DE

University Hospital Freiburg

Vortrag

Di., 22.10.
Poster presentation
P-II-0671
Enriching the diagnostic portfolio of the molecular tumor board with proteomics and phosphoproteomics of FFPE samples
Clinical Proteomics

Weitere Beteiligungen

Mo., 21.10.
Poster presentation
P-I-0313
Proteomic characterisation of clear cell renal cell carcinoma in patients with Von Hippel-Lindau Syndrome
Clinical Proteomics
Mo., 21.10.
Poster presentation
P-I-0372
Exploring proteomic signatures of high-grade serous carcinoma of the ovary
Clinical Proteomics
Mo., 21.10.
Poster presentation
P-I-0379
Single-shot mass spectrometry-based phosphoproteomic analysis of patient-derived formalin-fixed, parrafin-embedded samples reveal tissue specific fingerprints
Clinical Proteomics
Mo., 21.10.
Poster presentation
P-I-0311
Integrating proteomics into diagnostic molecular pathology reports to support molecular tumor board decisions
Clinical Proteomics
Mo., 21.10.
Poster presentation
P-I-0029
Secretome and degradome analysis reveal effects of Kallikrein-related peptidase 6 on ECM arrangement and immune recognition in PDAC
Defining Signaling Networks - Functional PTMs
Mo., 21.10.
Poster presentation
P-I-0157
A mass-spectrometry-based approach for the detection of gene fusion products
New Technology: MS-based Proteomics
Di., 22.10.
Poster presentation
P-II-0618
Proteomic characterization of Meningioma tissue and serum
Clinical Proteomics
Di., 22.10.
Poster presentation
P-II-0690
Insights from proteomic analysis in Crohn's disease
Clinical Proteomics
Di., 22.10.
Poster presentation
P-II-0692
Towards a noninvasive diagnosis of Peri-implantitis: proteomic analysis of Peri-implant crevicular fluid
Clinical Proteomics
Di., 22.10.
Poster presentation
P-II-0671
Enriching the diagnostic portfolio of the molecular tumor board with proteomics and phosphoproteomics of FFPE samples
Clinical Proteomics
Di., 22.10.
Poster presentation
P-II-0704
Proteomic profiling of IDH-wildtype glioblastoma reveals prognostic subtypes with matching abundances of semi-specific peptides in serum
Clinical Proteomics
Di., 22.10.
Poster presentation
P-II-0420
Designing a fully integrated microfluidic proteomic sample preparation workflow for clinical applications
New Technology: Sample Preparation
Mi., 23.10.
11:17 – 11:29 10 Min. 2 Min.
Oral presentation
OP-78
The proteomic and immunopeptidomic landscape of non-small cell lung cancer
Immunopeptidomics
Mi., 23.10.
Poster presentation
P-III-0966
Mass spectrometry-based proteomics to explore intratumoral heterogeneity in PAX3::FOXO1 fusion positive rhabdomyosarcoma
Cell Biology Insights
Mi., 23.10.
Poster presentation
P-III-1002
Analysis of mouse plasma proteome reveals systemic effects of Bothrops jararaca snake envenomation
Human Health Insights (Neurobiology, Cardiovascular, Liver, Kidney etc.)
Mi., 23.10.
Poster presentation
P-III-1086
Impact of dipeptidyl peptidase 9 on the MHC class I immunopeptidome
Immunopeptidomics